Assessing the intracranial metabolic score as a novel prognostic tool in primary CNS lymphoma with end of induction-chemotherapy 18F-FDG PET/CT and PET/MR
The IMS as a novel and effective prognostic tool for PCNSL patients, showing superior predictive value for patients' outcomes compared to the DS when assessed with EOT-PET scans.
Authors
- Mingshi Chen (ORCID: https://orcid.org/0000-0003-1224-8399)
- Chao Zhou (ORCID: https://orcid.org/0000-0003-1785-3969)
- Yiwen Mo
- Ruping Li
- Wei Fan (ORCID: https://orcid.org/0000-0002-0342-6272)
- Xinling Li (ORCID: https://orcid.org/0000-0003-3095-6911)
- Yongjiang Li (ORCID: https://orcid.org/0000-0003-2483-6841)
- Yuqian Huang
- Wei Yuan (ORCID: https://orcid.org/0009-0008-9623-0228)
- Xu Zhang (ORCID: https://orcid.org/0000-0002-7909-9378)
Institutions
- University of Electronic Science and Technology of China (CN)
- Sun Yat-sen University (CN)
- Zhengzhou University (CN)
- Sichuan Cancer Hospital (CN)
- Henan Cancer Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Cancer Imaging
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1186/s40644-024-00798-1
- Primary Topic
- CNS Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Science and Technology Department of Henan Province